{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:38:45Z","timestamp":1779356325838,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"DOI":"10.7759\/cureus.105380","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:07:10Z","timestamp":1773756430000},"source":"Crossref","is-referenced-by-count":1,"title":["Adoption and Practice Variability of Prostate Stereotactic Body Radiotherapy (SBRT) in Latin America: The Role of Continuous Education in Advancing Quality and Standardization"],"prefix":"10.7759","author":[{"given":"Pablo","family":"Castro Pena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes M","family":"Suarez Villasmil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Kupelian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleverson","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"International Agency for Research on Cancer. Cancer Today. GLOBOCAN. (2025). Accessed: December 23, 2025: https:\/\/gco.iarc.who.int\/today\/.."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00380","article-title":"A systematic review of radiotherapy capacity in low- and middle-income countries","volume":"4","author":"Grover S","year":"2014","unstructured":"Grover S, Xu MJ, Yeager A, et al.. A systematic review of radiotherapy capacity in low- and middle-income countries. Front Oncol. 2014, 4:380. 10.3389\/fonc.2014.00380","journal-title":"Front Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5603\/RPOR.a2022.0108","article-title":"Hypofractionation as a solution to radiotherapy access in latin america: expert perspective","volume":"27","author":"Santos M","year":"2022","unstructured":"Santos M, Chavez-Nogueda J, Galvis JC, et al.. Hypofractionation as a solution to radiotherapy access in latin america: expert perspective. Rep Pract Oncol Radiother. 2022, 27:1094-105. 10.5603\/RPOR.a2022.0108","journal-title":"Rep Pract Oncol Radiother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun R","year":"2015","unstructured":"Atun R, Jaffray DA, Barton MB, et al.. Expanding global access to radiotherapy. Lancet Oncol. 2015, 16:1153-86. 10.1016\/S1470-2045(15)00222-3","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00299-1","article-title":"Radiotherapy resources in Latin America and the Caribbean: a review of current and projected needs based on International Atomic Energy Agency data","volume":"24","author":"Elbanna M","year":"2023","unstructured":"Elbanna M, Pynda Y, Kalinchuk O, Rosa A, Abdel-Wahab M. Radiotherapy resources in Latin America and the Caribbean: a review of current and projected needs based on International Atomic Energy Agency data. Lancet Oncol. 2023, 24:376-84. 10.1016\/S1470-2045(23)00299-1","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2016.11.001","article-title":"Improving quality and access to radiation therapy-an IAEA perspective","volume":"27","author":"Abdel-Wahab M","year":"2017","unstructured":"Abdel-Wahab M, Zubizarreta E, Polo A, Meghzifene A. Improving quality and access to radiation therapy-an IAEA perspective. Semin Radiat Oncol. 2017, 27:109-17. 10.1016\/j.semradonc.2016.11.001","journal-title":"Semin Radiat Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.04.001","article-title":"Taking Guatemala from cobalt to IMRT: a tale of US agency collaboration with academic institutions and industry","volume":"107","author":"Velarde A","year":"2020","unstructured":"Velarde A, Najera KD, Gay H, et al.. Taking Guatemala from cobalt to IMRT: a tale of US agency collaboration with academic institutions and industry. Int J Radiat Oncol Biol Phys. 2020, 107:867-72. 10.1016\/j.ijrobp.2020.04.001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30158-3","article-title":"Oncology training in Latin America: are we ready for 2040?","volume":"21","author":"Duma N","year":"2020","unstructured":"Duma N, Moraes FY. Oncology training in Latin America: are we ready for 2040?. Lancet Oncol. 2020, 21:1267-8. 10.1016\/S1470-2045(20)30158-3","journal-title":"Lancet Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/GO.20.00562","article-title":"Global access to radiotherapy-work in progress","volume":"7","author":"Gospodarowicz M","year":"2021","unstructured":"Gospodarowicz M. Global access to radiotherapy-work in progress. JCO Glob Oncol. 2021, 7:144-5. 10.1200\/GO.20.00562","journal-title":"JCO Glob Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.7397","article-title":"Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer","volume":"35","author":"Catton CN","year":"2017","unstructured":"Catton CN, Lukka H, Gu CS, et al.. Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer. J Clin Oncol. 2017, 35:1884-90. 10.1200\/JCO.2016.71.7397","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree AC","year":"2022","unstructured":"Tree AC, Ostler P, Voet H van der, et al.. Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial. Lancet Oncol. 2022, 23:1308-20. 10.1016\/S1470-2045(22)00517-4","journal-title":"Lancet Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer","volume":"391","author":"van As N","year":"2024","unstructured":"van As N, Griffin C, Tree A, et al.. Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer. N Engl J Med. 2024, 391:1413-25. 10.1056\/NEJMoa2403365","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2966","article-title":"Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results","volume":"9","author":"Zilli T","year":"2020","unstructured":"Zilli T, Jorcano S, Bral S, et al.. Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results. Cancer Med. 2020, 9:3097-106. 10.1002\/cam4.2966","journal-title":"Cancer Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.03.051","article-title":"Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies","volume":"104","author":"Jackson WC","year":"2019","unstructured":"Jackson WC, Silva J, Hartman HE, et al.. Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies. Int J Radiat Oncol Biol Phys. 2019, 104:778-89. 10.1016\/j.ijrobp.2019.03.051","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2024.12.015","article-title":"Two-fraction versus five-fraction stereotactic body radiotherapy for intermediate-risk prostate cancer: the TOFFEE meta-analysis of individual patient data from four prospective trials","volume":"8","author":"Udovicich C","year":"2025","unstructured":"Udovicich C, Cheung P, Chu W, et al.. Two-fraction versus five-fraction stereotactic body radiotherapy for intermediate-risk prostate cancer: the TOFFEE meta-analysis of individual patient data from four prospective trials. Eur Urol Oncol. 2025, 8:763-73. 10.1016\/j.euo.2024.12.015","journal-title":"Eur Urol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02445","article-title":"Long-term analysis of NRG Oncology RTOG 0415: a randomized phase III noninferiority study comparing two fractionation schedules in patients with low-risk prostate cancer","volume":"42","author":"Lee WR","year":"2024","unstructured":"Lee WR, Dignam JJ, Amin MB, et al.. Long-term analysis of NRG Oncology RTOG 0415: a randomized phase III noninferiority study comparing two fractionation schedules in patients with low-risk prostate cancer. J Clin Oncol. 2024, 42:2377-81. 10.1200\/JCO.23.02445","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103072","article-title":"Impact of a SBRT\/SRS longitudinal telehealth training pilot course in Latin America","volume":"154","author":"Li B","year":"2020","unstructured":"Li B, Sarria GR, Hermansen M, et al.. Impact of a SBRT\/SRS longitudinal telehealth training pilot course in Latin America. Crit Rev Oncol Hematol. 2020, 154:103072. 10.1016\/j.critrevonc.2020.103072","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.851849","article-title":"Longitudinal remote SBRT\/SRS training in Latin America: a prospective cohort study","volume":"12","author":"Sarria GR","year":"2022","unstructured":"Sarria GR, Timmerman R, Hermansen M, et al.. Longitudinal remote SBRT\/SRS training in Latin America: a prospective cohort study. Front Oncol. 2022, 12:851849. 10.3389\/fonc.2022.851849","journal-title":"Front Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.13345","article-title":"Automated treatment planning of prostate stereotactic body radiotherapy with focal boosting on a fast-rotating O-ring linac: plan quality comparison with C-arm linacs","volume":"22","author":"De Roover R","year":"2021","unstructured":"De Roover R, Crijns W, Poels K, Dewit B, Draulans C, Haustermans K, Depuydt T. Automated treatment planning of prostate stereotactic body radiotherapy with focal boosting on a fast-rotating O-ring linac: plan quality comparison with C-arm linacs. J Appl Clin Med Phys. 2021, 22:59-72. 10.1002\/acm2.13345","journal-title":"J Appl Clin Med Phys"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.12057","article-title":"Linac-based stereotactic radiosurgery (SRS) in the treatment of refractory trigeminal neuralgia: detailed description of SRS procedure and reported clinical outcomes","volume":"18","author":"Pokhrel D","year":"2017","unstructured":"Pokhrel D, Sood S, McClinton C, et al.. Linac-based stereotactic radiosurgery (SRS) in the treatment of refractory trigeminal neuralgia: detailed description of SRS procedure and reported clinical outcomes. J Appl Clin Med Phys. 2017, 18:136-43. 10.1002\/acm2.12057","journal-title":"J Appl Clin Med Phys"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.13380","article-title":"Comparison of treatment plans for hypofractionated high-dose prostate cancer radiotherapy using the Varian Halcyon and the Elekta Synergy platforms","volume":"22","author":"Tamihardja J","year":"2021","unstructured":"Tamihardja J, Razinskas G, Exner F, et al.. Comparison of treatment plans for hypofractionated high-dose prostate cancer radiotherapy using the Varian Halcyon and the Elekta Synergy platforms. J Appl Clin Med Phys. 2021, 22:262-70. 10.1002\/acm2.13380","journal-title":"J Appl Clin Med Phys"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.13427","article-title":"Fast generation of lung SBRT plans with a knowledge-based planning model on ring-mounted Halcyon Linac","volume":"22","author":"Visak J","year":"2021","unstructured":"Visak J, Webster A, Bernard ME, Kudrimoti M, Randall ME, McGarry RC, Pokhrel D. Fast generation of lung SBRT plans with a knowledge-based planning model on ring-mounted Halcyon Linac. J Appl Clin Med Phys. 2021, 22:54-63. 10.1002\/acm2.13427","journal-title":"J Appl Clin Med Phys"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark A","year":"2019","unstructured":"Widmark A, Gunnlaugsson A, Beckman L, et al.. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial. Lancet. 2019, 394:385-95. 10.1016\/S0140-6736(19)31131-6","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.06.008","article-title":"Patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer","volume":"102","author":"Lukka HR","year":"2018","unstructured":"Lukka HR, Pugh SL, Bruner DW, et al.. Patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer. Int J Radiat Oncol Biol Phys. 2018, 102:287-95. 10.1016\/j.ijrobp.2018.06.008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref25","unstructured":"MexicanGoldenEagle. Latin America Regions - Wikipedia. (2011). Accessed: March 3, 2026: https:\/\/es.wikipedia.org\/wiki\/Archivo."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-01681-6","article-title":"Strict bladder filling and rectal emptying during prostate SBRT: Does it make a dosimetric or clinical difference?","volume":"15","author":"Byun DJ","year":"2020","unstructured":"Byun DJ, Gorovets DJ, Jacobs LM, et al.. Strict bladder filling and rectal emptying during prostate SBRT: Does it make a dosimetric or clinical difference?. Radiat Oncol. 2020, 15:239. 10.1186\/s13014-020-01681-6","journal-title":"Radiat Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01174","article-title":"Increased dose to organs in urinary tract associates with measures of genitourinary toxicity in pooled voxel-based analysis of 3 randomized phase iii trials","volume":"10","author":"Marcello M","year":"2020","unstructured":"Marcello M, Denham JW, Kennedy A, et al.. Increased dose to organs in urinary tract associates with measures of genitourinary toxicity in pooled voxel-based analysis of 3 randomized phase iii trials. Front Oncol. 2020, 10:1174. 10.3389\/fonc.2020.01174","journal-title":"Front Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210142","article-title":"Dosimetric feasibility of stereotactic irradiation of primary prostate cancer at 5x9 Gy with a method of urethral sparing","volume":"94","author":"Benhmida S","year":"2021","unstructured":"Benhmida S, Beneux A, Udrescu C, et al.. Dosimetric feasibility of stereotactic irradiation of primary prostate cancer at 5x9 Gy with a method of urethral sparing. Br J Radiol. 2021, 94:20210142. 10.1259\/bjr.20210142","journal-title":"Br J Radiol"},{"key":"ref29","article-title":"Assessment of the state of the RT of SBRT in Prostate Cancer in Latin America: The HUG-Clinical Working Group Initiative","volume":"17","author":"Castro Pe\u00f1a P","year":"2025","unstructured":"Castro Pe\u00f1a P, Kupelian P, Lopes C. Assessment of the state of the RT of SBRT in Prostate Cancer in Latin America: The HUG-Clinical Working Group Initiative. Cureus. 2025, 17:1385.","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/471556-adoption-and-practice-variability-of-prostate-stereotactic-body-radiotherapy-sbrt-in-latin-america-the-role-of-continuous-education-in-advancing-quality-and-standardization","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:07:12Z","timestamp":1773756432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/471556-adoption-and-practice-variability-of-prostate-stereotactic-body-radiotherapy-sbrt-in-latin-america-the-role-of-continuous-education-in-advancing-quality-and-standardization"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.105380","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,17]]}}}